We are live on ! Find out more
VNRX icon

VolitionRx Ltd

34 hedge funds and large institutions have $8.02M invested in VolitionRx Ltd in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more call options, than puts

Call options by funds: $172K | Put options by funds: $45K

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

10% more funds holding

Funds holding: 3134 (+3)

0.04% less ownership

Funds ownership: 0.55%0.51% (-0.04%)

34% less capital invested

Capital invested by funds: $12.2M → $8.02M (-$4.2M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
8
Reduced
7
Closed
3
Calls
$172K
Puts
$45K
Net Calls
+$127K
Net Calls Change
+$77K

VNRX Hedge Fund Activity: Q3 2022 in Review

34 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2022, worth a combined $8.02M — down 34% from $12.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VNRX positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Bank Julius Baer & Co, opening a new position worth an estimated $279K. The largest seller was Lagoda Investment Management, cutting an estimated $328K.

  • 34 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2022, up from 31 in Q2 2022.
  • Funds reported $8.02M of VolitionRx Ltd stock for Q3 2022, down 34% quarter-over-quarter.
  • 6 funds opened new VolitionRx Ltd positions in Q3 2022 and 3 closed out, a net change of +3 holders.
  • The largest VolitionRx Ltd buyer in Q3 2022 was Bank Julius Baer & Co, an estimated $279K added.
  • The largest VolitionRx Ltd seller in Q3 2022 was Lagoda Investment Management, an estimated $328K sold.

Based on aggregated 13F filings for Q3 2022.